Atlas Trials

Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection

Clinical trial NCT04747574 · UNKNOWN

Trial details

NCT number
NCT04747574
Sponsor
Tel-Aviv Sourasky Medical Center
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
SARS-CoV-2
Start date
2020-09-25
Primary completion
2021-02-25
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.